Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Occupational Health & Safety (Waco, Tex.)
|
April 1, 2003
The perfect eight-hour refresher--does it exist?
T Skaar
Journal of Medicinal Food
|
March 14, 2009
Use of ERE and reporter gene constructs to assess putative estrogenic activity
R Clarke, T Skaar, D El-Ashry, et al.
Clinical Pharmacology and Therapeutics
|
April 17, 2009
Clinically available pharmacogenomics tests
D A Flockhart, T Skaar, D S Berlin, et al.
The Pharmacogenomics Journal
|
May 1, 2013
Efavirenz-mediated induction of omeprazole metabolism is CYP2C19 genotype dependent
V Michaud, Y Kreutz, T Skaar, et al.
British Journal of Cancer
|
September 1, 1999
Prepubertal exposure to zearalenone or genistein reduces mammary tumorigenesis
L Hilakivi-Clarke, I Onojafe, M Raygada, et al.
Cancer Treatment and Research
|
January 1, 1996
Acquisition of an antiestrogen-resistant phenotype in breast cancer: role of cellular and molecular mechanisms
R Clarke, T Skaar, F Leonessa, et al.
Breast Cancer Research and Treatment
|
January 1, 1994
Hormonal carcinogenesis in breast cancer: cellular and molecular studies of malignant progression
R Clarke, T Skaar, K Baumann, et al.
Neurogastroenterology and Motility
|
April 25, 2008
Relationship of cytochrome P450 pharmacogenetics to the effects of yohimbine on gastrointestinal transit and catecholamines in healthy subjects
A E Bharucha, T Skaar, C N Andrews, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 17, 2009
A phase II study of pemetrexed as second-line chemotherapy for the treatment of metastatic castrate-resistant prostate cancer (CRPC); Hoosier Oncology Group GU03-67
N M Hahn, R T Zon, M Yu, et al.
Clinical Pharmacology and Therapeutics
|
January 21, 2011
The emerging role of electronic medical records in pharmacogenomics
R A Wilke, H Xu, J C Denny, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Occupational Health & Safety (Waco, Tex.)
|
April 1, 2003
The perfect eight-hour refresher--does it exist?
T Skaar
Journal of Medicinal Food
|
March 14, 2009
Use of ERE and reporter gene constructs to assess putative estrogenic activity
R Clarke, T Skaar, D El-Ashry, et al.
Clinical Pharmacology and Therapeutics
|
April 17, 2009
Clinically available pharmacogenomics tests
D A Flockhart, T Skaar, D S Berlin, et al.
The Pharmacogenomics Journal
|
May 1, 2013
Efavirenz-mediated induction of omeprazole metabolism is CYP2C19 genotype dependent
V Michaud, Y Kreutz, T Skaar, et al.
British Journal of Cancer
|
September 1, 1999
Prepubertal exposure to zearalenone or genistein reduces mammary tumorigenesis
L Hilakivi-Clarke, I Onojafe, M Raygada, et al.
Cancer Treatment and Research
|
January 1, 1996
Acquisition of an antiestrogen-resistant phenotype in breast cancer: role of cellular and molecular mechanisms
R Clarke, T Skaar, F Leonessa, et al.
Breast Cancer Research and Treatment
|
January 1, 1994
Hormonal carcinogenesis in breast cancer: cellular and molecular studies of malignant progression
R Clarke, T Skaar, K Baumann, et al.
Neurogastroenterology and Motility
|
April 25, 2008
Relationship of cytochrome P450 pharmacogenetics to the effects of yohimbine on gastrointestinal transit and catecholamines in healthy subjects
A E Bharucha, T Skaar, C N Andrews, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 17, 2009
A phase II study of pemetrexed as second-line chemotherapy for the treatment of metastatic castrate-resistant prostate cancer (CRPC); Hoosier Oncology Group GU03-67
N M Hahn, R T Zon, M Yu, et al.
Clinical Pharmacology and Therapeutics
|
January 21, 2011
The emerging role of electronic medical records in pharmacogenomics
R A Wilke, H Xu, J C Denny, et al.
Page
of 2